Anacor Pharma (ANAC) Posts Mixed Q4 Results
Tweet Send to a FriendGet Alerts ANAC Hot Sheet
Trade ANAC Now!
Anacor Pharmaceuticals (NASDAQ: ANAC) reported Q4 EPS of ($0.73), $0.26 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $1.6 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- TiVo, Inc. (TIVO) Tops Q1 EPS by 6c; Issues Solid Q2 Rev Outlook
- Campbell Soup Co. (CPB) Tops Q3 EPS by 6c; Boosts FY13 Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
